Drug company executives faced tough questions from Congress on Tuesday as they attempted to explain why, thanks to high drug prices, per capita spending on pharmaceuticals in the United States is double the average of other advanced countries. For decades, American drug makers have justified these high…
AIR ANALYSIS
Comments on economic issues and developments published by AIR researchers and affiliates
How High Drug Prices Inflate C.E.O.s’ Pay
Pharmaceutical companies say their profits fund research and innovation in new medicines, but they are spending billions to enrich shareholders and executives.
What is the purpose of a corporation? (with William Lazonick and Lenore Palladino)
By Nick Hanauer “Interview with William Lazonick and Lenore Palladino: explain why ‘shareholder-value maximization us the world’s dumbest idea.”… [Click HERE to listen the interview]
Stock buybacks: Free-market ideology’s license to loot
By William Lazonick, speaker at the forum “William Lazonick, Professor Emeritus, U Mass Lowell, speaks at the forum, “Destroying the Myths of Market Fundamentalism,” held in Washington DC”… [Click HERE to watch the talk]
Who benefits from stock buybacks
William Lazonick, segment guest [Click HERE to listen the talk]
Apple’s “Capital Return Program”: Where Are the Patient Capitalists?
By William Lazonick “The enormous revenues and profits flowing from Apple’s innovative products, the iPhone in particular, get primary credit for enabling the company to be the first in history to reach a trillion-dollar market capitalization. That financial achievement, attained…
The Problem with Paying Executives in Stock
By Patricia Kotnik and Mustafa Erdem Sakinc “Executive compensation in Europe: Realized gains from stock-based pay. In the ongoing recovery of the global economy from the Great Recession a decade ago, real wages in both the United States and Europe continue…
How hedge fund activists prey on companies
By Jang-Sup Shin “The casual observer can hardly comprehend the value-extracting power of hedge fund activists. Technically, they are no more than minority shareholders. Yet they exert enormous influence, often forcing these companies to undertake fundamental restructuring and to increase…
The Rise of Hedge Fund Activism
By Jang-Sup Shin “The casual observer can hardly comprehend the value-extracting power of hedge fund activists. Technically, they are no more than minority shareholders.”… [Click HERE to read the full article]
Who is watching Wall Street?
By Lenore Palladino “Since the ink dried on the GOP tax plan, officially known as the Tax Cut and Jobs Act, back in December 2017, companies have spent over $218 billion dollars re-purchasing their own stock at the going price…